Steric Effects in the Aerobic Oxidation of π-Allylnickel(II)
(49 mg, 0.64 mmol) was then added dropwise to this suspension
while the vial was swirled. A solution of IMes (196 mg, 0.46 mmol)
in toluene (2 mL) was then added. The residual IMes was
transferred with toluene rinses (2 × 1 mL). The vial was swirled
by hand until the mixture became homogeneous (ca. 3 min). The
reaction mixture was then concentrated to dryness under a vacuum
to yield the product as an orange solid (277 mg, 98% yield).
1H NMR (300 MHz, C6D6): δ 1.18 (d, 1H, J ) 13 Hz, allyl-H),
2.09 (s, 7H, Ar-Me), 2.15 (s, 6H, Ar-Me), 2.32 (s, 6H, Ar-Me),
2.46 (d, J ) 14 Hz, 1H, allyl-H), 3.31 (d, J ) 6.8 Hz, 1H, allyl-
H), 4.63 (sept, J ) 6.8 Hz, 1H, allyl-H), 6.16 (s, 2H, RNCHCHNR),
6.76 (s, 1H, Ar-H), 6.83 (s, 1H, Ar-H). 13C NMR {1H} (75 MHz,
C6D6): δ 18.55, 18.66, 21.06, 43.52, 69.64, 107.42, 122.88, 129.33,
129.38, 135.93, 135.96, 136.53, 138.78, 186.19. IR (KBr): 3166-
(m), 3140(m), 3075(w), 2916(s), 2855(m), 1487(s), 1398(s), 1330-
(s), 1268(m), 1230(m), 1076(w), 1038(m), 927(m), 900(m), 851(s),
741(m), 705(m). HRMS (EI) m/Z: (M)+ calcd, 438.1362; obsd,
438.1367.
2922(m), 1748(s), 1458(s), 1411(s), 1335(s), 1255(m), 1208(s), 996-
(s), 935(s), 849(m), 668(w), 494(w) cm-1. HRMS (EI) m/Z: (M)+
calcd, 342.0655; obsd, 342.0650.
Allyl(ICy)NiCl (1g). ICy-HBF4 (106 mg, 0.33 mmol), KOtBu
(39 mg, 0.35 mmol), and thf (5-mL) were added to a scintillation
vial, and the resulting mixture was stirred for 1h. The mixture was
diluted with toluene (2 mL) and concentrated under a vacuum to
ca. 2 mL. The reaction mixture was then diluted with toluene (1
mL) and hexanes (7 mL), mixed by pipet for ca. 2 min, and filtered
over Celite. The solids were washed with hexanes (2 × 1 mL).
The filtrate was combined and concentrated to ca. 1 mL under a
vacuum. Ni(cod)2 (91 mg, 0.33 mmol) and cod (∼400 mg) were
added to a 20 mL scintillation vial. Allyl chloride (25 mg, 0.33
mmol) was then added dropwise to the resulting suspension of Ni-
(cod)2, resulting in the appearance of a red color. After the vial
was swirled until all of the solid Ni(cod)2 disappeared (∼5 min),
the solution of ICy in toluene was added dropwise to the nickel/
cod/allyl chloride mixture; residual ICy was rinsed with toluene (2
× 1 mL). This resulted in the formation of a brown heterogeneous
mixture, which was filtered over Celite to remove a green solid.
The filtrate was diluted with hexanes (9 mL) and cooled to -25
°C overnight. An orange-brown precipitate formed and was isolated
by pipeting off the solvent and drying the solid under a vacuum to
yield the product (62 mg, 51%yield).
Allyl(ItBu)NiCl (1d). Ni(cod)2 (125 mg, 0.46 mmol) was
suspended in cod (ca. 750 mg) in a scintillation vial. Allyl chloride
(35 mg, 0.46 mmol) was then added dropwise to this suspension
while the vial was swirled. A solution of ItBu (82 mg, 0.46 mmol)
in toluene (2 mL) was added. The ItBu was then rinsed with toluene
(2 × 1 mL). The vial was swirled by hand until the mixture became
homogeneous (ca. 3 min). The reaction mixture was then concen-
trated to dryness under a vacuum to yield the product as an orange
solid (144 mg, >99% yield). The product has 1H NMR data
identical to the literature values.12 Crystals suitable for X-ray
analysis were obtained by cooling a solution of 1d in 1:1 toluene:
hexanes to -25 °C.
Allyl(IAd)NiCl (1e). Ni(cod)2 (138 mg, 0.50 mmol) was
suspended in cod (ca. 400 mg) in a scintillation vial. Allyl chloride
(38 mg, 0.50 mmol) was then added dropwise to this suspension
while the vial was swirled. A solution of IAd (168 mg, 0.50 mmol)
in toluene (2 mL) was then added. The IAd was rinsed with toluene
(2 × 1 mL). The vial was swirled by hand until the mixture became
homogeneous (ca. 5 min). The reaction mixture was then concen-
trated to dryness under a vacuum to yield the product as an orange
solid (233 mg, 98% yield). The product has 1H NMR data identical
to the literature values.12
1H NMR (300 MHz, C6D6): δ 0.8-1.0 (m, 2H, cy-H), 1.0-2.0
(m, 17H, cy-H), 1.87 (m, 1H, cy-H), 2.30 (m, 2H, cy-H), 2.61 (d,
J ) 10 Hz, 1H, allyl-H), 3.01 (d, J ) 14 Hz, 1H, allyl-H), 3.82 (d,
J ) 7.6 Hz, 1H, allyl-H), 4.76 (br s, 1H, NCHR2), 5.18 (sept, J )
6.7 Hz, 1H, allyl-H), 5.56 (br s, 1H, NCHR2), 6.34 (s, 1H,
RNCHCHNR), 6.41 (s, 1H, RNCHCHNR). 13C NMR {1H} (75
MHz, C6D6): δ 25.50, 25.55, 25.59, 25.67, 25.91, 34.08, 34.24,
34.43, 42.69, 59.80, 60.39, 68.50, 107.24, 117.51, 180.84. IR
(KBr): 2931(s), 2852(s), 1450(m), 1422(m), 1380(m), 1238(m),
1201(s), 895(w), 866(w), 724(s), 699(m), 424(m), 409(w) cm-1
HRMS (EI) m/Z: (M)+ calcd, 366.1403; obsd, 366.1388.
.
Allyl(ITol)NiCl (1h). Ni(cod)2 (171 mg, 0.62 mmol) was
suspended in cod (ca. 1 g) in a scintillation vial. Allyl chloride (48
mg, 0.62 mmol) was then added dropwise to this suspension while
the vial was swirled. A mixture of ITol (154 mg, 0.62 mmol) in
toluene (3 mL) was then added. The ITol was then rinsed over
with toluene (4 × 1 mL). The mixture was swirled for ca. 5 min
and then concentrated under a vacuum. The product was then
crystallized from toluene/hexanes at -25 °C to yield an orange
solid (149 mg, 63% yield).
1H NMR (300 MHz, C6D6): δ 1.10 (d, J ) 12 Hz, 1H, allyl-H),
1.89 (dt, J ) 6.8 Hz, 2.4 Hz, 1H, allyl-H), 2.05 (s, 6H, Ar-Me),
2.80 (d, J ) 14 Hz, 1H, allyl-H), 3.70 (dd, J ) 2.4 Hz, 7.6 Hz,
1H, allyl-H), 4.76 (sept, J ) 6.8 Hz, 1H, allyl-H), 6.54 (br s, 1H,
RNCHCHNR), 6.61 (br s, 1H, RNCHCHNR), 6.96 (d, J ) 7.8
Hz, 2H, Ar-H), 7.02 (d, J ) 7.8 Hz, 2H, Ar-H), 8.01 (d, J ) 7.8
Hz, 2H, Ar-H), 8.44 (d, J ) 7.6 Hz, 2H, Ar-H). 13C NMR {1H}
(75 MHz, C6D6): δ 20.89, 43.03, 68.23, 107.49, 121.85, 122.14,
124.51, 124.85, 127.81, 127.87, 129.98, 130.03, 137.79, 138.06,
185.22. IR (KBr): 3173(w), 3140(m), 3110(w), 3054(m), 3033-
(m), 2918(m), 1514(s), 1409(s), 1338(m), 1273(s), 942(m), 888-
(m), 821(s), 717(m), 682(m) cm-1; Anal. Calcd for C20H21ClN2-
Ni: C, 62.63; H, 5.52; N, 7.30. Found: C, 62.43; H, 5.69; N, 7.37.
MeItBu-HI. 1-t-Butyl-1H-imidazole30 (544 mg, 4.4 mmol) was
added to a 25 mL round-bottomed flask equipped with a stirbar
and dissolved in thf (5 mL). Iodomethane (301µL, 4.8 mmol) was
added to this solution, and the reaction mixture was stirred
Allyl(IBioxMe4)NiCl (1f). IBioxMe4-HOTf (112 mg, 0.33
mmol) and KOtBu (39 mg, 0.34 mmol) were dissolved in thf (3
mL) in a scintillation vial and stirred for 2 h. Benzene (2 mL) was
then added to the resulting solution to precipitate KOTf. Ni(cod)2
(90 mg, 0.33 mmol) was suspended in 1,5-cod (ca. 400 mg) in a
second scintillation vial. Allyl chloride (26 mg, 0.34 mmol) was
added to the suspension of Ni(cod)2, resulting in a color change
from yellow to red. The thf/benzene mixture containing IBioxMe4
was then pipet-filtered over Celite directly into the Ni/allyl chloride/
1,5-cod mixture, followed by 2 × 1 mL rinses with benzene. The
resulting orange solution was concentrated to dryness under a
vacuum to yield a brown solid. The complex was then dissolved
in thf (3 mL), filtered over Celite into a scintillation vial, layered
with hexane (10 mL), and cooled to -25 °C to yield brown prisms
(83 mg, 74%). Crystals suitable for X-ray analysis were obtained
by cooling a solution of 1f in 1:2 toluene:hexanes to -25 °C.
1H NMR (300 MHz, d8-thf): δ 1.58-1.72 (m, 7H, overlapping
allyl-H and CR3Me), 1.87 (s, 3H, CR3Me), 2.00 (s, 3H, CR3Me),
2.39 (d, J ) 6.3 Hz, 1H, allyl-H), 2.66 (d, J ) 14 Hz, 1H, allyl-
H), 3.30 (d, J ) 6.6 Hz, 1H, allyl-H), 4.51 (dt, J ) 24 Hz, 8.2 Hz,
4H, ROCH2CR2N), 5.24 (sept, J ) 6.6 Hz, 1H, allyl-H). 13C NMR
{1H} (75 MHz, d8-thf): δ 25.85, 26.61, 26.67, 44.80, 61.57, 62.06,
68.38, 88.43, 88.57, 108.01, 126.94, 159.37. IR (KBr): 2964(m),
(30) Liu, J.; Chen, J.; Zhao, J.; Zhao, Y.; Li, L.; Zhang, H. Synthesis 2003,
2661-2666.
Inorganic Chemistry, Vol. 45, No. 20, 2006 8439